KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Total Non-Current Liabilities (2016 - 2025)

Globus Medical (GMED) has disclosed Total Non-Current Liabilities for 15 consecutive years, with $560.4 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Total Non-Current Liabilities fell 43.52% year-over-year to $560.4 million, compared with a TTM value of $560.4 million through Jun 2025, down 43.52%, and an annual FY2024 reading of $1.1 billion, down 1.0% over the prior year.
  • Total Non-Current Liabilities was $560.4 million for Q2 2025 at Globus Medical, up from $505.0 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.1 billion in Q3 2023 and bottomed at $138.9 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $496.1 million, with a median of $211.3 million recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities skyrocketed 512.3% in 2024, then tumbled 44.5% in 2025.
  • Year by year, Total Non-Current Liabilities stood at $203.2 million in 2021, then rose by 7.96% to $219.4 million in 2022, then skyrocketed by 384.73% to $1.1 billion in 2023, then fell by 1.0% to $1.1 billion in 2024, then crashed by 46.77% to $560.4 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for GMED at $560.4 million in Q2 2025, $505.0 million in Q1 2025, and $1.1 billion in Q4 2024.